139 related articles for article (PubMed ID: 33795806)
21. Alternative splicing and caspase-mediated cleavage generate antagonistic variants of the stress oncoprotein LEDGF/p75.
Brown-Bryan TA; Leoh LS; Ganapathy V; Pacheco FJ; Mediavilla-Varela M; Filippova M; Linkhart TA; Gijsbers R; Debyser Z; Casiano CA
Mol Cancer Res; 2008 Aug; 6(8):1293-307. PubMed ID: 18708362
[TBL] [Abstract][Full Text] [Related]
22. LEDGF/p75-independent HIV-1 replication demonstrates a role for HRP-2 and remains sensitive to inhibition by LEDGINs.
Schrijvers R; De Rijck J; Demeulemeester J; Adachi N; Vets S; Ronen K; Christ F; Bushman FD; Debyser Z; Gijsbers R
PLoS Pathog; 2012; 8(3):e1002558. PubMed ID: 22396646
[TBL] [Abstract][Full Text] [Related]
23. ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia.
Zhu L; Li Q; Wong SH; Huang M; Klein BJ; Shen J; Ikenouye L; Onishi M; Schneidawind D; Buechele C; Hansen L; Duque-Afonso J; Zhu F; Martin GM; Gozani O; Majeti R; Kutateladze TG; Cleary ML
Cancer Discov; 2016 Jul; 6(7):770-83. PubMed ID: 27154821
[TBL] [Abstract][Full Text] [Related]
24. Menin as a hub controlling mixed lineage leukemia.
Thiel AT; Huang J; Lei M; Hua X
Bioessays; 2012 Sep; 34(9):771-80. PubMed ID: 22829075
[TBL] [Abstract][Full Text] [Related]
25. Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering.
Vanegas M; Llano M; Delgado S; Thompson D; Peretz M; Poeschla E
J Cell Sci; 2005 Apr; 118(Pt 8):1733-43. PubMed ID: 15797927
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the HIV-1 integrase chromatin- and LEDGF/p75-binding abilities by mutagenic analysis within the catalytic core domain of integrase.
Zheng Y; Ao Z; Jayappa KD; Yao X
Virol J; 2010 Mar; 7():68. PubMed ID: 20331877
[TBL] [Abstract][Full Text] [Related]
27. Expression of the stress response oncoprotein LEDGF/p75 in human cancer: a study of 21 tumor types.
Basu A; Rojas H; Banerjee H; Cabrera IB; Perez KY; De León M; Casiano CA
PLoS One; 2012; 7(1):e30132. PubMed ID: 22276150
[TBL] [Abstract][Full Text] [Related]
28. [LEDGF/p75: a novel target for anti-HIV therapy and advances in the study of its related inhibitors].
Chen WM; Liu XY
Yao Xue Xue Bao; 2009 Sep; 44(9):953-60. PubMed ID: 20055168
[TBL] [Abstract][Full Text] [Related]
29. LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells.
Maertens G; Cherepanov P; Pluymers W; Busschots K; De Clercq E; Debyser Z; Engelborghs Y
J Biol Chem; 2003 Aug; 278(35):33528-39. PubMed ID: 12796494
[TBL] [Abstract][Full Text] [Related]
30. Virological and cellular roles of the transcriptional coactivator LEDGF/p75.
Llano M; Morrison J; Poeschla EM
Curr Top Microbiol Immunol; 2009; 339():125-46. PubMed ID: 20012527
[TBL] [Abstract][Full Text] [Related]
31. The interaction of LEDGF/p75 with integrase is lentivirus-specific and promotes DNA binding.
Busschots K; Vercammen J; Emiliani S; Benarous R; Engelborghs Y; Christ F; Debyser Z
J Biol Chem; 2005 May; 280(18):17841-7. PubMed ID: 15749713
[TBL] [Abstract][Full Text] [Related]
32. Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus.
Vandekerckhove L; Christ F; Van Maele B; De Rijck J; Gijsbers R; Van den Haute C; Witvrouw M; Debyser Z
J Virol; 2006 Feb; 80(4):1886-96. PubMed ID: 16439544
[TBL] [Abstract][Full Text] [Related]
33. LEDGF/p75 TATA-less promoter is driven by the transcription factor Sp1.
Desfarges S; Abderrahmani A; Hernàndez-Novoa B; Munoz M; Ciuffi A
J Mol Biol; 2011 Nov; 414(2):177-93. PubMed ID: 22019592
[TBL] [Abstract][Full Text] [Related]
34. Identification of the H3K36me3 reader LEDGF/p75 in the pancancer landscape and functional exploration in clear cell renal cell carcinoma.
Zhang Y; Guo W; Feng Y; Yang L; Lin H; Zhou P; Zhao K; Jiang L; Yao B; Feng N
Comput Struct Biotechnol J; 2023; 21():4134-4148. PubMed ID: 37675289
[TBL] [Abstract][Full Text] [Related]
35. Over-Expression of LEDGF/p75 in HEp-2 Cells Enhances Autoimmune IgG Response in Patients with Benign Prostatic Hyperplasia-A Novel Diagnostic Approach with Therapeutic Consequence?
Liedtke V; Rose L; Hiemann R; Nasser A; Rödiger S; Bonaventura A; Winkler L; Sowa M; Stöckle M; Schierack P; Junker K; Roggenbuck D
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047137
[TBL] [Abstract][Full Text] [Related]
36. Identification of small peptides inhibiting the integrase-LEDGF/p75 interaction through targeting the cellular co-factor.
Cavalluzzo C; Christ F; Voet A; Sharma A; Singh BK; Zhang KY; Lescrinier E; De Maeyer M; Debyser Z; Van der Eycken E
J Pept Sci; 2013 Oct; 19(10):651-8. PubMed ID: 24014475
[TBL] [Abstract][Full Text] [Related]
37. Lens epithelium-derived growth factor (LEDGF/p75) expression in fetal and adult human brain.
Chylack LT; Fu L; Mancini R; Martin-Rehrmann MD; Saunders AJ; Konopka G; Tian D; Hedley-Whyte ET; Folkerth RD; Goldstein LE
Exp Eye Res; 2004 Dec; 79(6):941-8. PubMed ID: 15642333
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75.
Llano M; Vanegas M; Hutchins N; Thompson D; Delgado S; Poeschla EM
J Mol Biol; 2006 Jul; 360(4):760-73. PubMed ID: 16793062
[TBL] [Abstract][Full Text] [Related]
39. The transcriptional co-activator LEDGF/p75 displays a dynamic scan-and-lock mechanism for chromatin tethering.
Hendrix J; Gijsbers R; De Rijck J; Voet A; Hotta J; McNeely M; Hofkens J; Debyser Z; Engelborghs Y
Nucleic Acids Res; 2011 Mar; 39(4):1310-25. PubMed ID: 20974633
[TBL] [Abstract][Full Text] [Related]
40. The Competitive Interplay between Allosteric HIV-1 Integrase Inhibitor BI/D and LEDGF/p75 during the Early Stage of HIV-1 Replication Adversely Affects Inhibitor Potency.
Feng L; Dharmarajan V; Serrao E; Hoyte A; Larue RC; Slaughter A; Sharma A; Plumb MR; Kessl JJ; Fuchs JR; Bushman FD; Engelman AN; Griffin PR; Kvaratskhelia M
ACS Chem Biol; 2016 May; 11(5):1313-21. PubMed ID: 26910179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
